They observed a significantly higher distribution of CD8+ and CD4+ Tumour-Infiltrating Lymphocytes (TILs), which exhibit a small fraction of infiltrating CD4+ Foxp3+ Tregs indicating clinical effectiveness (142). This evidence concerns the gene FOXP3 and neoplasm.